Spend on cancer per patient in England 2006 - 2007

£7,923

Compare this with other PCTs: highest amount spent was £17,028, lowest was £5,182, and average PCT spend per cancer patient was £8,437.

Exceptional funding for cancer treatment

The following information was requested from the PCT in 2008 under the Freedom of Information Act.

Written protocols
Written protocols used by the PCT to assess exceptional requests for treatments in general - this covers cancer treatment.

Cancer treatments funded by PCT following exceptional requests
Since 01 October 2006, the following requests were approved:

• Sunitinib <5
• Mylotarg <5
• Dasatinib <5
• Pemetrexed <5
• Raltitrexed <5
• Sorafenib <5
• Tarceva (Erlotinib) <5
  

Cancer treatments not funded by PCT following exceptional requests
Since 01 October 2006, the following treatments were not funded:

• Dasatinib <5
• Temozolomide <5
• Cetuximab 25
• Sorafenib   5
• Pemetrexed <5
• Sunitinib 11
• Tarceva (Erlotinib) <5
• Erythropoietin <5
• Avastin <5